Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL1077269 | 1.00 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Oxalic Acid SCHEMBL2493636 | 0.97 | ALDH1A1 (0.65) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL384127 | 0.92 | — | — | |
| Imidazole SCHEMBL3374317 | 0.92 | ALDH1A1 (0.72) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL6336331 | 0.92 | ALDH1A1 (0.72) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL1894404 | 0.92 | ALDH1A1 (0.72) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL15152163 | 0.90 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL28097518 | 0.90 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL28097519 | 0.90 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL5838661 | 0.89 | ALDH1A1 (0.87) | ALDH1A1FKBP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3164527-B1 | SYNTHESIS AND USE OF BIO-BASED IMIDAZOLIUM CARBOXYLATES | UNIV BOURGOGNE (FR) | 2019-04-17 | — | — | EP | claimed |
| US-9863048-B2 | Synthesis and use of biobased imidazolium carboxylates | Université de Bourgogne (FR) | 2018-01-09 | — | — | US | claimed |
| US-20160002796-A1 | SYNTHESIS AND USE OF BIOBASED IMIDAZOLIUM CARBOXYLATES | Université de Bourgogne (FR) | 2016-01-07 | — | — | US | claimed |
| EP-2963155-A1 | Synthesis and use of biobased imidazolium carboxylates | Université de Bourgogne (FR) | 2016-01-06 | — | — | EP | claimed |
| CN-101863910-B | Ionic rare-earth metal organic coordination polymer and preparation method thereof | INST PROCESS ENG CAS | 2014-02-26 | — | — | CN | claimed |
| CN-101863910-A | Ionic rare-earth metal organic coordination polymer and preparation method thereof | INST PROCESS ENG CAS | 2010-10-20 | — | — | CN | claimed |
| CN-101265268-B | Ionic rare earth metal organic coordination polymer and preparation method thereof | INST PROCESS ENG CAS | 2010-08-25 | — | — | CN | claimed |
| CN-101265268-A | Ionic rare earth metal organic coordination polymer and preparation method thereof | INST PROCESS ENG CAS (CN) | 2008-09-17 | — | — | CN | claimed |
| CN-100393720-C | Cyclic benzimidazoles. | ALTANA PHARMA AG (DE) | 2008-06-11 | — | — | CN | claimed |
| CN-105924637-B | A method of polyoxyalkylene polymers of the production containing crosslinkable silyl | 陶氏环球技术有限责任公司 | 2019-04-19 | — | — | CN | disclosed |
| EP-3164527-B1 | SYNTHESIS AND USE OF BIO-BASED IMIDAZOLIUM CARBOXYLATES | UNIV BOURGOGNE (FR) | 2019-04-17 | — | — | EP | disclosed |
| CN-108219255-A | A kind of antistatic quasi-polyethylene material and preparation method thereof | 董燕琦 | 2018-06-29 | — | — | CN | disclosed |
| EP-3322527-A1 | METHOD FOR PREPARING BIOSOURCED IONIC LIQUIDS FOR CATALYSIS | Université de Bourgogne (FR) | 2018-05-23 | — | — | EP | disclosed |
| US-9863048-B2 | Synthesis and use of biobased imidazolium carboxylates | Université de Bourgogne (FR) | 2018-01-09 | — | — | US | disclosed |
| CN-100393720-C | Cyclic benzimidazoles. | ALTANA PHARMA AG (DE) | 2008-06-11 | — | — | CN | disclosed |
| CN-1764662-A | Cyclic benzimidazoles. | ALTANA PHARMA AG (DE) | 2006-04-26 | — | — | CN | disclosed |
| EP-1115705-A1 | NOVEL COMPOUNDS | AstraZeneca AB (SE) | 2001-07-18 | — | — | EP | disclosed |
| WO-2000018736-A1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 2000-04-06 | — | — | WO | disclosed |
| US-5025083-A | Process for preparation of polycarbonate | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1991-06-18 | — | — | US | disclosed |
| EP-0382250-A2 | Process for preparation of polycarbonate | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1990-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160002796-A1 | SYNTHESIS AND USE OF BIOBASED IMIDAZOLIUM CARBOXYLATES | IDH2, IDH1, HOGA1 | ALDH1A1 68/4885FKBP5 1455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.